Blog

A panel of U.S. Food and Drug Administration (FDA) advisors has convened in Gaithersburg, MD to discuss the future of transvaginal mesh products. The meeting was called after an influx of adverse events, regarding the surgical application of transvaginal mesh, had been reported in recent years. According to officials at the FDA, the meeting…

There have been numerous cases where patients have experienced failures involving Zimmer Durom hip replacement cups. It is believed by some that the company marketed the device knowing that it was defective and would result in a high rate of failure. If you or a loved one has been injured by a defective Zimmer…

September 13, 2011 witnessed two American advocacy groups attempt to hold the pope and the Vatican accountable in an international court, for what many are calling crimes against humanity. On Tuesday, the Center for Constitutional Rights and the Survivors Network of those Abused by Priests filed a complaint aimed directly at the Vatican. The…

According to federal health officials, a multi-state Salmonella outbreak continues to threaten states on the east coast. However, related cases of Salmonella poisoning have spread as far west as Texas. To date, the current outbreak has affected a total of 93 people in 19 separate states. While investigations by both the Centers for Disease…

On September 22, 2011, the European Medicines Agency (EMA) implemented stricter regulations on the already popular heart-rhythm drug Multaq. According to the EMA, there is “an increased risk of Multaq causing injury to the liver as well as the lungs when used in accordance with the currently approved prescribing information.” Subsequently, the U.S. Food…

On February 17, 2011 the U.S. Food & Drug Administration (FDA) added a “Black Box Warning” to Terbutaline. Terbutaline injections or infusion pump transmission has been linked to an increased risk of serious, life-threatening side effects including heart problems and death to fetus, neonate, and/or mother when administered to pregnant women. If you or…

An advisory committee was convened on September 8, 2011, by the U.S. Food and Drug Administration (FDA), that discussed the safety and effectiveness of transvaginal mesh devices. The meeting was intended to determine the future of such devices, therefore a federal advisory panel collected data in an attempt to determine if transvaginal mesh has…

Transvaginal mesh products find their origin in the history of surgical mesh. Once considered a revolutionary device in the treatment of abdominal hernias, surgical mesh has made the transition to transvaginal mesh. In the last decade the surgical application of transvaginal mesh has been used in the treatment of pelvic organ prolapse (POP), stress…